300026SZSE

Announcement of Resolutions from the 2025 Shareholders' Meeting

Tianjin Chasesun Pharmaceutical Co., Ltd.·May 20, 2026·4 pages

✨ AI Summary

The 2025 Shareholders' Meeting of Tianjin Chase Sun Pharmaceutical Co., Ltd. was held on April 21, 2026, with resolutions passed on the 2025 Annual Work Report, 2025 Profit Distribution Plan, 2026 Annual Work Plan, Senior Management and Remuneration Plan, and the election of an Independent Director. Key figures show overwhelming support for all resolutions, with over 99% of represented shares voting in favor. The meeting was legally compliant, and all resolutions are valid and effective.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Special Instructions:

This shareholders' meeting will not increase, change, or reject proposals.
This shareholders' meeting will combine on-site voting and network voting.

I. Opening and Attendance of the Meeting

Tianjin Chase Sun Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") convened the 2025 shareholders' meeting on April 21, 2026. This meeting adopted a combination of on-site and network voting. The on-site meeting is scheduled for May 20, 2026, at 14:30 at Tianjin Wuqing District B1 Building, through the Shenzhen Stock Exchange's voting system from May 20, 2026, 09:15 to 15:00. The network voting will occur from May 20, 2026, 09:15 to May 20, 2026, 15:00.

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.